Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial compounds from Grewia bilamellata.

Cuiying Ma1, Hong Jie Zhang, Ghee Teng Tan

  • 1Program for Collaborative Research in Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 60612, USA.

Journal of Natural Products
|March 28, 2006
PubMed
Summary

Grewia bilamellata yielded twelve compounds, with five showing antimalarial activity against Plasmodium falciparum without significant toxicity. Three novel compounds, including a triterpene and lignans, were identified from this plant extract.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Benzophenanthridine Alkaloids from <i>Zanthoxylum nitidum</i> That Target the MDM2-p53 Axis in NSCLC.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management.

International journal of rheumatic diseases·2026
Same author

[Application Of Next Generation Sequencing To Diagnosis Of <i>Mycobacterium Tuberculosis</i> Drug Resistant Directly From Sputum Sample In National Lung Hospital Since 2020 - 2022].

Tap chi y hoc du phong = Journal of preventive medicine·2026
Same author

[Determination Of Related Genetic Variations Resistance To Moxifloxacin From <i>Mycobacterium Tuberculosis</i> Strain In Hanoi From 2020 - 2022].

Tap chi y hoc du phong = Journal of preventive medicine·2026
Same author

Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy study.

The Lancet. Microbe·2026
Same author

Heterogeneous Water Diffusion on DWI/ADC in Moderately Differentiated Rectal Adenocarcinoma: A Case Report and Pathologic Correlation.

Current medical imaging·2026

Area of Science:

  • Natural Product Chemistry
  • Medicinal Chemistry
  • Pharmacognosy

Background:

  • Grewia bilamellata is a plant species with potential medicinal properties.
  • Natural products are a vital source for drug discovery, particularly for infectious diseases like malaria.

Purpose of the Study:

  • To isolate and characterize compounds from Grewia bilamellata.
  • To evaluate the antimalarial activity and cytotoxicity of isolated compounds.

Main Methods:

  • Bioassay-directed fractionation of plant extracts.
  • Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
  • In vitro antimalarial activity testing against Plasmodium falciparum.
  • Cytotoxicity assessment against the human oral epidermoid KB cancer cell line.

Related Experiment Videos

Main Results:

  • Twelve compounds were isolated from Grewia bilamellata leaves, twigs, and stems.
  • Five compounds exhibited in vitro antimalarial activity against Plasmodium falciparum.
  • Compounds 1 (3alpha,20-lupandiol), 2 (grewin), and 3 (bilagrewin) were identified as new chemical entities: a triterpene, a coumarinolignan, and a neolignan, respectively.
  • The isolated compounds showed no significant cytotoxicity to the KB cancer cell line.

Conclusions:

  • Grewia bilamellata is a source of novel bioactive compounds with potential antimalarial properties.
  • The identified compounds, particularly the new triterpene and lignans, warrant further investigation for antimalarial drug development.
  • The lack of cytotoxicity suggests a favorable safety profile for further preclinical studies.